Utility of the endobronchial Watanabe spigot for intractable cancer-related pneumothorax: a retrospective observational study.
Jpn J Clin Oncol
; 53(9): 829-836, 2023 Aug 30.
Article
em En
| MEDLINE
| ID: mdl-37340759
ABSTRACT
BACKGROUND:
The use of endobronchial Watanabe spigots for intractable secondary pneumothorax in patients with cancer has not been adequate. This study aimed to investigate the use of endobronchial Watanabe spigots for intractable pneumothorax in patients with malignant tumors.METHODS:
Consecutive patients with malignant tumors who underwent occlusion with an endobronchial Watanabe spigot for intractable pneumothorax associated with perioperative treatment or drug therapy at our institution between January 2014 and February 2022 were reviewed.RESULTS:
Of the 32 cases in which an endobronchial Watanabe spigot was used, six were excluded; we thus evaluated 26 cases in which the chest tube was removed. Chest tubes were removed in 19 cases (73.1%) and could not be removed and required surgical treatment under general anesthesia in seven patients (26.9%), of which four (14.8%) underwent open-window thoracostomy. Half of the patients were treated with both an endobronchial Watanabe spigot and pleurodesis. Although thin-slice chest computed tomography revealed a fistula in 15 patients, the chest tube was removed in 11 (57.9%) patients. A significant difference was only observed in patients with a history of heavy smoking.CONCLUSIONS:
The chest tube removal rate was comparable to those reported in previous studies. An endobronchial Watanabe spigot may be a useful treatment option for intractable cancer-related pneumothorax.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumotórax
/
Embolização Terapêutica
/
Neoplasias
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Jpn J Clin Oncol
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Japão